Patents by Inventor David N. Hurst

David N. Hurst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of HPV E1 helicase enzyme
    Patent number: 6703387
    Abstract: The invention is concerned with novel benzodiazepine derivatives, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds are inhibitors of the human papillomavirus E1 helicase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents for HPV mediated diseases.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: March 9, 2004
    Assignee: Hoffmann-La Roche Inc.
    Inventors: David N. Hurst, Philip Stephen Jones, Kevin Edward Burdon Parkes, Martin John Parratt, Francis Xavier Wilson
  • Inhibitors of HPV E1 helicase enzyme
    Publication number: 20020128262
    Abstract: The invention is concerned with novel benzodiazepine derivatives, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds are inhibitors of the human papillomavirus E1 helicase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents for HPV mediateddiseases.
    Type: Application
    Filed: June 26, 2001
    Publication date: September 12, 2002
    Inventors: David N. Hurst, Philip Stephen Jones, Kevin Edward Burdon Parkes, Martin John Parratt, Francis Xavier Wilson
  • Oxamide IMPDH inhibitors
    Publication number: 20020052513
    Abstract: Disclosed are compounds of the general formula 1
    Type: Application
    Filed: February 8, 2001
    Publication date: May 2, 2002
    Inventors: Michael J. Broadhurst, Christopher H. Hill, David N. Hurst, Philip S. Jones, Paul B. Kay, Ian R. Kilford, Robert M. McKinnell